Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003
Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008
Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006
Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005
Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010
Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Treatment of pulmonary hypertension in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313 Year: 2006
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012
Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
Comorbidities in the course of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010
Phenotypic characteristics of patients with arterial hypertension and chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012
Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002